GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (STU:8BD) » Definitions » Revenue

Boule Diagnostics AB (STU:8BD) Revenue : €49.93 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boule Diagnostics AB Revenue?

Boule Diagnostics AB's revenue for the three months ended in Sep. 2024 was €11.50 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €49.93 Mil. Boule Diagnostics AB's Revenue per Share for the three months ended in Sep. 2024 was €0.30. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €1.26.

Warning Sign:

Boule Diagnostics AB revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Boule Diagnostics AB was -9.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Boule Diagnostics AB's highest 3-Year average Revenue per Share Growth Rate was 11.80% per year. The lowest was -3.90% per year. And the median was 4.90% per year.


Boule Diagnostics AB Revenue Historical Data

The historical data trend for Boule Diagnostics AB's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB Revenue Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.60 39.36 45.11 49.86 51.08

Boule Diagnostics AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.81 13.24 13.07 12.13 11.50

Competitive Comparison of Boule Diagnostics AB's Revenue

For the Medical Devices subindustry, Boule Diagnostics AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Revenue distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Revenue falls into.



Boule Diagnostics AB Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €49.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boule Diagnostics AB  (STU:8BD) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Boule Diagnostics AB Revenue Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB Business Description

Traded in Other Exchanges
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines